WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-seventh report
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Geneva
World Health Organization
2003
|
| Schriftenreihe: | Technical report series (World Health Organization)
908 |
| Schlagworte: | |
| Beschreibung: | viii, 145 p |
| ISBN: | 9241209089 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044122758 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2003 |||| o||u| ||||||eng d | ||
| 020 | |a 9241209089 |9 92-4-120908-9 | ||
| 035 | |a (ZDB-30-PAD)EBC284793 | ||
| 035 | |a (ZDB-89-EBL)EBL284793 | ||
| 035 | |a (OCoLC)191039475 | ||
| 035 | |a (DE-599)BVBBV044122758 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.19 | |
| 110 | 2 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations |b Meeting < 2001, Geneva, Switzerland> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations |b thirty-seventh report |
| 264 | 1 | |a Geneva |b World Health Organization |c 2003 | |
| 300 | |a viii, 145 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Technical report series (World Health Organization) |v 908 | |
| 505 | 0 | |a 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals | |
| 650 | 4 | |a Drugs |x Standards |v Congresses | |
| 650 | 4 | |a Drugs |x Specifications |v Congresses | |
| 650 | 4 | |a Pharmaceutical industry |x Quality control |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029529603 | ||
Datensatz im Suchindex
| _version_ | 1804177204870905856 |
|---|---|
| any_adam_object | |
| author_corporate | WHO Expert Committee on Specifications for Pharmaceutical Preparations Meeting < 2001, Geneva, Switzerland> |
| author_corporate_role | aut |
| author_facet | WHO Expert Committee on Specifications for Pharmaceutical Preparations Meeting < 2001, Geneva, Switzerland> |
| author_sort | WHO Expert Committee on Specifications for Pharmaceutical Preparations Meeting < 2001, Geneva, Switzerland> |
| building | Verbundindex |
| bvnumber | BV044122758 |
| collection | ZDB-30-PAD |
| contents | 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals |
| ctrlnum | (ZDB-30-PAD)EBC284793 (ZDB-89-EBL)EBL284793 (OCoLC)191039475 (DE-599)BVBBV044122758 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02618nmm a2200361zcb4500</leader><controlfield tag="001">BV044122758</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2003 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9241209089</subfield><subfield code="9">92-4-120908-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)191039475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044122758</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="b">Meeting < 2001, Geneva, Switzerland></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="b">thirty-seventh report</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Geneva</subfield><subfield code="b">World Health Organization</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 145 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Technical report series (World Health Organization)</subfield><subfield code="v">908</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Specifications</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Quality control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029529603</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV044122758 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:44:22Z |
| institution | BVB |
| isbn | 9241209089 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029529603 |
| oclc_num | 191039475 |
| open_access_boolean | |
| physical | viii, 145 p |
| psigel | ZDB-30-PAD |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | World Health Organization |
| record_format | marc |
| series2 | Technical report series (World Health Organization) |
| spelling | WHO Expert Committee on Specifications for Pharmaceutical Preparations Meeting < 2001, Geneva, Switzerland> Verfasser aut WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report Geneva World Health Organization 2003 viii, 145 p txt rdacontent c rdamedia cr rdacarrier Technical report series (World Health Organization) 908 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals Drugs Standards Congresses Drugs Specifications Congresses Pharmaceutical industry Quality control Congresses (DE-588)1071861417 Konferenzschrift gnd-content |
| spellingShingle | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals Drugs Standards Congresses Drugs Specifications Congresses Pharmaceutical industry Quality control Congresses |
| subject_GND | (DE-588)1071861417 |
| title | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_auth | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_exact_search | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_full | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_fullStr | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_full_unstemmed | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report |
| title_short | WHO Expert Committee on Specifications for Pharmaceutical Preparations |
| title_sort | who expert committee on specifications for pharmaceutical preparations thirty seventh report |
| title_sub | thirty-seventh report |
| topic | Drugs Standards Congresses Drugs Specifications Congresses Pharmaceutical industry Quality control Congresses |
| topic_facet | Drugs Standards Congresses Drugs Specifications Congresses Pharmaceutical industry Quality control Congresses Konferenzschrift |
| work_keys_str_mv | AT whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsmeeting2001genevaswitzerland whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyseventhreport |